Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients - Université de Bretagne Occidentale Access content directly
Journal Articles Archives of cardiovascular diseases Year : 2018

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

No file

Dates and versions

hal-02055852 , version 1 (04-03-2019)

Identifiers

  • HAL Id : hal-02055852 , version 1

Cite

Jean-Guillaume Dillinger, Boris Aleil, Saida Cheggour, Ygal Benhamou, Yannick Béjot, et al.. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases, 2018, 111 (2), pp.85-94. ⟨hal-02055852⟩
43 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More